Try GOLD - Free
H-word, M-word & fading K-word
Business Standard
|June 14, 2025
If the only superpower, which calls India an ally, sees the region through an India-Pakistan prism, it is unacceptable. Rather than endorse India's sphere of influence, this undermines it
Much as I would've wanted to use "khota sikka", the challenge of finding an exact translation brings me to the usual bad penny. Let's say, therefore, that like a bad penny, the dreaded H-word is back with us — H, as in hyphenation with Pakistan.
And its return is dreaded because our successive governments have laboured for three decades to rid us of what we see as the equivalence the big powers (read the United States) used to draw between us and Pakistan. Three things follow.
Let's call the first the "zero-sum game". If Washington sees the subcontinent in a hyphenated manner, then it must balance the relationship. Gain for one is loss for the other. It brings an equivalence India detests. It believes it stands in a class by itself and linking with Pakistan demeans it.
The second can be called "stature denial". Given its growing comprehensive national power (CNP), India believes it deserves a sphere of influence. If Washington, an ally, sees the region through an India-Pakistan prism, it's unacceptable. Rather than endorse India's sphere of influence, this undermines it.
This is double trouble as China is already working hard at denying India that pre-eminence. And whereas India would expect US backing in this competition, it is galling when the US keeps saying sweet somethings to Pakistan. We thought we were partners in a project to contain China through Quad.
And the third, this means the return of the M-word that so triggers us — M for mediation. For Indian public opinion, American President Donald Trump has undone the work of the past decades by continuing to insist that he mediated the India-Pakistan ceasefire. Now, we know that his interest isn't in any mediation but in getting credit: "Nobody gives me credit for stopping a nuclear war", "I stopped a nuclear war and I haven't seen any stories about it", and so on.
This story is from the June 14, 2025 edition of Business Standard.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Business Standard
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
